icatibant
Generic: icatibant
Labeler: teva pharmaceuticals usa, inc.Drug Facts
Product Profile
Brand Name
icatibant
Generic Name
icatibant
Labeler
teva pharmaceuticals usa, inc.
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
icatibant acetate 10 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
0093-3066
Product ID
0093-3066_56c3b3d7-5c66-422c-a72d-30b3599d71db
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA210118
Listing Expiration
2026-12-31
Marketing Start
2019-07-15
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
00933066
Hyphenated Format
0093-3066
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
icatibant (source: ndc)
Generic Name
icatibant (source: ndc)
Application Number
ANDA210118 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 10 mg/mL
Packaging
- 1 SYRINGE in 1 CARTON (0093-3066-34) / 3 mL in 1 SYRINGE
- 3 CARTON in 1 BOX (0093-3066-93) / 1 SYRINGE in 1 CARTON (0093-3066-19) / 3 mL in 1 SYRINGE
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "56c3b3d7-5c66-422c-a72d-30b3599d71db", "openfda": {"unii": ["325O8467XK"], "rxcui": ["1148141"], "spl_set_id": ["402a20e0-d1e2-4a24-ae1d-f2ff6d8fa7b3"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE in 1 CARTON (0093-3066-34) / 3 mL in 1 SYRINGE", "package_ndc": "0093-3066-34", "marketing_start_date": "20190715"}, {"sample": false, "description": "3 CARTON in 1 BOX (0093-3066-93) / 1 SYRINGE in 1 CARTON (0093-3066-19) / 3 mL in 1 SYRINGE", "package_ndc": "0093-3066-93", "marketing_start_date": "20190715"}], "brand_name": "Icatibant", "product_id": "0093-3066_56c3b3d7-5c66-422c-a72d-30b3599d71db", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Bradykinin B2 Receptor Antagonist [EPC]", "Bradykinin B2 Receptor Antagonists [MoA]"], "product_ndc": "0093-3066", "generic_name": "Icatibant", "labeler_name": "Teva Pharmaceuticals USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Icatibant", "active_ingredients": [{"name": "ICATIBANT ACETATE", "strength": "10 mg/mL"}], "application_number": "ANDA210118", "marketing_category": "ANDA", "marketing_start_date": "20190715", "listing_expiration_date": "20261231"}